ライフサイエンスコーパス: fluorescein

1 ating PM disruption and cytosolic release of fluorescein.

2 titative assay based on the hydrophilic dye, fluorescein.

3 Green-emitting fluorescein-5-isothiocyanate (FITC) was conjugated to th

4 ation can also enhance the pH sensitivity of fluorescein, a well-known pH-sensitive dye, within a lar

5 ansmembrane helix B with the fluorescent dye fluorescein (acetamidofluorescein).

6 Single-stranded DNA probes labeled with fluorescein amidite (FAM-ssDNA), ethidium bromide (EB),

7 heranostic LiLa formulation with gadolinium, fluorescein and "eat-me" phagocytic signals (Gd-FITC-LiL

8 iRGD delivered attached fluorescein and co-applied nanoparticles deep into fresh

9 therapeutics, FIP-1 links two fluorophores (fluorescein and Cy3) through an Fe(II)-cleavable endoper

10 mination including color fundus photography, fluorescein and indocyanine green angiographies, spectra

11 n, fundoscopy, optical coherence tomography, fluorescein and indocyanine green angiography in a 66 ye

12 Small-molecule fluorophores, such as fluorescein and rhodamine derivatives, are critical tool

13 were first discovered in the 1800s, and the fluorescein and rhodamine scaffolds have been known for

14 adial peripapillary capillary network in the fluorescein and SSADA scans and the proportion of the in

15 tic dye produced by the action of bromine on fluorescein and stains basic proteins due to its acidic

16 n, and propranolol) and two model compounds (fluorescein and sulforhodamine B) from porous media foll

17 to existing methods using simulated spectra, Fluorescein and TAMRA dye mixtures as a zero FRET contro

18 dyes of different photochemical properties (fluorescein and texas red).

19 methods and correlated them with OSDI, TBUT, fluorescein, and lissamine along with adjusted and aggre

20 correlate with fluorophotometry: OSDI, TBUT, fluorescein, and lissamine.

21 tained for acetazolamide, riboflavin, sodium fluorescein, and theophylline in 2-hydroxyethyl methacry

22 Fluorescein angiogram characteristics included staining

23 tection and assessment of leakage in retinal fluorescein angiogram images is important for the manage

24 ally detect intravascular filling defects in fluorescein angiogram images.

25 as seen in SSADA scans that would match the fluorescein angiogram.

26 35.9% vs 6.2%, P = .04), vascular leakage on fluorescein angiograms (FA) (44.4% vs 12.5%, P = .03), a

27 of GA in digital color photographs (CPs) and fluorescein angiograms (FAs) taken at baseline and years

28 d vascular patterns than were visible on the fluorescein angiograms although within a more posterior

29 Digital color photographs and fluorescein angiograms at baseline and 1 and 2 years wer

30 retinal periphery that were obscured in the fluorescein angiograms by fluorescein staining from unde

31 These distinct layers were compared with the fluorescein angiograms in 12 healthy eyes from patients

32 asked readers and compared with conventional fluorescein angiograms of the same eyes.

33 Comparison of fundus photographs with fluorescein angiograms showed that in 13/18 eyes (72%),

34 Fluorescein angiograms were examined by 2 experts to doc

35 The fluorescein angiograms were matched, with a mean proport

36 examination of RetCam fundus photographs and fluorescein angiograms.

37 ch MIOCT angiograms and clinically indicated fluorescein angiograms.

38 uclear layer on spectral-domain OCT, with no fluorescein angiographic correlate.

39 Eyes with baseline fluorescein angiographic leakage were more likely to imp

40 autofluorescence (FAF), dynamic simultaneous fluorescein angiography (FA) and indocyanine green angio

41 Concurrent fluorescein angiography (FA) and indocyanine green angio

42 V detection compared to the gold standard of fluorescein angiography (FA) and OCT was determined for

43 of patients who underwent same-day OCTA and fluorescein angiography (FA) for suspected CNV was evalu

44 Baseline fluorescein angiography (FA) images of all CATT study ey

45 Color fundus photography and fluorescein angiography (FA) images were used to create

46 evaluated digital color fundus photographs, fluorescein angiography (FA) images, and optical coheren

47 Detecting CNV using fluorescein angiography (FA) may be challenging owing to

48 Fluorescein angiography (FA) may become necessary to eva

49 Fluorescein angiography (FA) showed nonspecific retinal

50 Digital retinal imaging and fluorescein angiography (FA) were performed at an averag

51 atients underwent SS OCT angiography (OCTA), fluorescein angiography (FA), and indocyanine green angi

52 examination including structural OCT, OCT-A, fluorescein angiography (FA), and indocyanine green angi

53 pectral-domain optical coherence tomography, fluorescein angiography (FA), and indocyanine green angi

54 Fundus photography, OCT, fluorescein angiography (FA), and OCT angiography were p

55 w-up morphology in color fundus photographs, fluorescein angiography (FA), and optical coherence tomo

56 ollow-up morphology on digital color images, fluorescein angiography (FA), and optical coherence tomo

57 We performed following examinations: fluorescein angiography (FA), B-scan ultrasound, spectra

58 ding visual acuity (VA), fundus photography, fluorescein angiography (FA), fundus autofluorescence (F

59 Imaging features obtained using fluorescein angiography (FA), indocyanine green angiogra

60 raphy, fundus photography, autofluorescence, fluorescein angiography (FA), optical coherence tomograp

61 photography, fundus autofluorescence (FAF), fluorescein angiography (FA), spectral-domain optical co

62 ed by optical coherence tomography (OCT) and fluorescein angiography (FA).

63 art, optical coherence tomography (OCT), and fluorescein angiography (FA).

64 d with commercially available 70-kHz OCT and fluorescein angiography (FA).

65 d sizes and locations that were confirmed by fluorescein angiography (FA).

66 Traditionally, fundus fluorescein angiography (FFA) has been considered the re

67 raphy (ERG), fundus photography (FP), fundus fluorescein angiography (FFA), and optical coherence tom

68 Pretreatment ocular characteristics on fluorescein angiography (lesion type, area of neovascula

69 nce of cataract (P = .05), foveal leakage on fluorescein angiography (P = .04), and increased central

70 inical study to determine if ultra-widefield fluorescein angiography (UWFA), spectral-domain optical

71 graded scar and GA on fundus photography and fluorescein angiography and graded SHRM on time-domain a

72 Visual acuity, color images, and fluorescein angiography and indocyanine green angiograph

73 Retinal fluorescein angiography and optical coherence tomography

74 without diabetic macular edema and underwent fluorescein angiography and SD-OCT for diabetic retinopa

75 r more at 6 months, the change in leakage on fluorescein angiography and the change in foveal thickne

76 zation and/or peripheral avascular retina on fluorescein angiography and were treated with laser.

77 of the retina, a layer poorly visualized by fluorescein angiography and, to a lesser extent, in the

78 This information in combination with ICG and fluorescein angiography can help to optimize direct lase

79 ection rate, or optical coherence tomography/fluorescein angiography changes).

80 ocular coherence tomography (OCT), and with fluorescein angiography confirmation.

81 Fluorescein angiography confirmed the sea fan neovascula

82 Fluorescein angiography does not image the radial peripa

83 Fluorescein angiography had the highest accuracy (97%, 3

84 Fluorescein angiography has shown potentially serious an

85 Ultra-widefield fluorescein angiography images were obtained in 63 eyes

86 s was used to perform ultra-widefield fundus fluorescein angiography in infants undergoing an examina

87 e has advantages as an alternative to RetCam fluorescein angiography in infants undergoing an examina

88 g tool for performing ultra-widefield fundus fluorescein angiography in infants.

89 nificantly reduced LPC/DHA transport in vivo Fluorescein angiography indicated normal blood-retinal b

90 Fluorescein angiography is important in assessing vascul

91 Although fluorescein angiography is the criterion standard for ev

92 Fluorescein angiography leakage was associated with a gr

93 tral-domain optical coherence tomography and fluorescein angiography of inner foveal structural abnor

94 Intravenous fluorescein angiography performed in 1 eye depicted the

95 Fluorescein angiography revealed early hypofluorescence

96 e large choroidal vessels and optic atrophy; fluorescein angiography revealed gradual restoration of

97 Fluorescein angiography showed a late hyperfluorescence

98 Fluorescein angiography showed filling defects in retina

99 Fluorescein angiography showed staining during the late

100 erwent intraoperative ultra-widefield fundus fluorescein angiography using the modified Heidelberg Sp

101 Fluorescein angiography was performed in 17 of 43 diabet

102 Ultra-widefield fundus fluorescein angiography was successfully performed in al

103 Optical coherence tomography (OCT) and fluorescein angiography were also obtained at some visit

104 with type of choroidal neovascularization on fluorescein angiography were not confirmed.

105 traretinal cysts on SD OCT or dye leakage on fluorescein angiography) and responded to treatment with

106 abnormalities are typically evaluated using fluorescein angiography, a modality with known defects i

107 cs, such as early onset, cuticular drusen on fluorescein angiography, and family history of AMD.

108 gnosed with RAP based on fundus examination, fluorescein angiography, and indocyanine green angiograp

109 anibizumab, bevacizumab, fundus photographs, fluorescein angiography, and optical coherence tomograph

110 a-ocular pressure, results of fundoscopy and fluorescein angiography, and outcomes two months after t

111 isions on the need to perform or not perform fluorescein angiography, and regarding treatment or retr

112 free photographs, near-infrared reflectance, fluorescein angiography, and spectral-domain optical coh

113 r pigment (MP), OCT, blue light reflectance, fluorescein angiography, as well as fundus photography,

114 ment of retinal detachment was assessed with fluorescein angiography, clinical examination, or both.

115 imethod imaging comprised color photography, fluorescein angiography, fundus autofluorescence, and hi

116 r each patient, including color photography, fluorescein angiography, fundus autofluorescence, and op

117 in all patients and were hyperfluorescent on fluorescein angiography, hypofluorescent on ICG angiogra

118 omplete ophthalmologic examination including fluorescein angiography, indocyanine green angiography,

119 d reflectance scanning laser ophthalmoscopy, fluorescein angiography, indocyanine green angiography,

120 h various combinations of color photography, fluorescein angiography, indocyanine green angiography,

121 rapeutic technologies, including intravenous fluorescein angiography, laser photocoagulation, optical

122 provider was $282.80, with 4 imaging tests (fluorescein angiography, magnetic resonance imaging, che

123 Among 467 eyes with fluorescein angiography, mean total lesion area was 12.9

124 l color imaging, spectral-domain OCT images, fluorescein angiography, OCT angiography images, and en

125 andard 7-field stereo fundus photography and fluorescein angiography, respectively.

126 gathering included fundus color photographs, fluorescein angiography, spectral-domain optical coheren

127 olor photographs, near-infrared reflectance, fluorescein angiography, spectral-domain optical coheren

128 ging findings, including fundus photography, fluorescein angiography, spectral-domain optical coheren

129 uate retinal capillary blood flow instead of fluorescein angiography, the reflectance pattern of bloo

130 autofluorescence, and indocyanine green and fluorescein angiography, was available in most cases.

131 ence tomography (SD-OCT) and nonperfusion on fluorescein angiography, we observed that retinal capill

132 sualized completely around the nerve head by fluorescein angiography, whereas the network was readily

133 linical examination, fundus photography, and fluorescein angiography.

134 etinal capillary flow data in the absence of fluorescein angiography.

135 ptical coherence tomography (OCT) and fundus fluorescein angiography.

136 with resolved macular edema, and leakage on fluorescein angiography.

137 hy, wide-field color fundus photography, and fluorescein angiography.

138 a, with higher resolution than observed with fluorescein angiography.

139 al vasculature with lower risk and cost than fluorescein angiography.

140 inal blood flow velocities measured by video fluorescein angiography.

141 , optical coherence tomography (OCT), and/or fluorescein angiography.

142 teristics on optical coherence tomography or fluorescein angiography.

143 sions are visible on clinical examination or fluorescein angiography.

144 esions visible on ICGA but not detectable on fluorescein angiography.

145 s the late staining seen during conventional fluorescein angiography.

146 ain optical coherence tomography, and fundus fluorescein angiography.

147 RS) scale, optical coherence tomography, and fluorescein angiography.

148 al iris vessels, not distinct on intravenous fluorescein angiography.

149 were more distinct on OCTA than intravenous fluorescein angiography.

150 (SD OCT), fundus autofluorescence (FAF), and fluorescein angiography/indocyanine green (ICG) angiogra

151 giography, fundus autofluorescence (FAF) and fluorescein-angiography (FA).

152 nt release of ROS as measured by aminophenyl fluorescein (APF) and ARE-FLuc luciferase assays, and ~4

153 , we developed sensitive assays that use the fluorescein arsenical dye FlAsH (fluorescein arsenical h

154 Using a panel of intramolecular fluorescein arsenical hairpin (FlAsH) bioluminescence re

155 hat use the fluorescein arsenical dye FlAsH (fluorescein arsenical hairpin binder) to detect soluble

156 The probe employs a fluorescein as a fluorophore, and is equipped with an op

157 e of the device was initially performed with fluorescein as a test molecule.

158 ied the real-time intracellular release of a fluorescein at a single-cell resolution.

159 ne of the primers for each set labelled with fluorescein, biotin and digoxigenin coding for S. enteri

160 dation of dihydrorhodamine 123, AAPH-induced fluorescein bleaching and hypochlorite-induced fluoresce

161 uorescein bleaching and hypochlorite-induced fluorescein bleaching.

162 Fluorescein concentration of DED and normal patients sho

163 Different fluorescein concentrations in CaSO4 beads were evaluated

164 ss the capillary bed with the small molecule fluorescein, concomitant with reactive astrocytosis.

165 tion of electroactive alpha-naphthol by anti-fluorescein-conjugated alkaline phosphatase.

166 adhesive-dentin interface were covered with fluorescein-conjugated gelatin and observed with a multi

167 Fluorescence intensity emitted by hydrolyzed fluorescein-conjugated gelatin was quantified, and the a

168 damage correlated with rapid accumulation of fluorescein-conjugated paclitaxel in epidermal basal ker

169 asculature without the need for injection of fluorescein contrast dye.

170 eight (mm), tear break-up time (s), inferior fluorescein corneal staining (National Eye Institute [NE

171 r, tear meniscus height, tear break-up time, fluorescein corneal staining) at 6 months within plug gr

172 HADA), green (NBD-amino-D-alanine, NADA, and fluorescein-D-lysine, FDL) or red (TAMRA-D-lysine, TDL)

173 The delivery of Fluorescein-Dextran into 3T3 mouse fibroblast cells was

174 We assessed sputum microscopy with fluorescein diacetate (FDA, evaluating M. tuberculosis m

175 ative of the 5-carboxyl group from 5-carboxy-fluorescein diacetate or from Oregon green diacetate or

176 ha were measured as proliferation by carboxy-fluorescein diacetate succinimidyl ester dye dilution an

177 losis quantitative viability microscopy with fluorescein diacetate, quantitative culture, and acid-fa

178 esophageal stent to demonstrate delivery of fluorescein diacetate, using applied tension, to an ex v

179 The approach is based on embedding fluorescein dilaurate (FDL), a fluorogenic ester substra

180 Compared with the use of 3,6-fluorescein diphosphate as a signal reporter in an ALP-l

181 ce resonance energy transfer (FRET) from the fluorescein donor to Cy3 acceptor by splitting these two

182 led with 5-([4,6-dichlorotriazin-2-yl]amino) fluorescein (DTAF), detected by high-performance liquid

183 itoring the enzymatic cohydrolysis of FDL to fluorescein during enzymatic hydrolysis of the polyester

184 tween DED and normal eyes up to 30 min after fluorescein dye instillation.

185 Fluorescein dye was then placed into both eyes, rinsed w

186 had a baseline fluorescein scan prior to any fluorescein dye.

187 unctionalized nopoldiol reagent labeled with fluorescein dye.

188 Using sodium fluorescein extravasation, we found that CD2AP(-/-) mice

189 Fluorescein (FA) and indocyanine green (ICGA) angiograph

190 n of single stranded DNA labeled with either fluorescein (FAM) or tetramethylrhodamine (TAMRA) with a

191 in the meantime, generate a large number of fluorescein (FAM)-encapsulated liposomes.

192 Two probes, one based on fluorescein (FHDB) and the other based on rhodamine (RDD

193 This derivatization altogether abolishes fluorescein fluorescence and renders the molecule prone

194 Fluorescein fundus angiography soon after cutting the PC

195 ophthalmoscopy, color fundus photography and fluorescein fundus angiography, before and immediately a

196 s that incorporate butyrylcholinesterase and fluorescein in a nanoscale arrangement.

197 fied by the intense intra-retinal leakage of fluorescein in combination with other associated feature

198 kHz and yield detection limits of 400 nM for fluorescein in water.

199 el was evaluated using a fluorescent tracer (fluorescein) incorporated in the carrier materials calci

200 Mechanical properties of fluorescein-incorporated beads were analyzed.

201 s to a vascular evaluation by a simultaneous fluorescein/indocyanine green angiography.

202 ficantly enhanced penetration of an attached fluorescein into disseminated peritoneal tumor nodules.

203 Introducing a fluorescent dye (0.1% [w/w] fluorescein) into the phloem water of the tree species E

204 ith d-lysine conjugated rhodamine-lactam and fluorescein isocyanate (FITC) leads to efficient metabol

205 Conjugation of fluorescein isothiocyanate (10.86 +/- 0.94 percentage in

206 the dyes in their free isothiocyanate forms, fluorescein isothiocyanate (F-ITC) and tetramethylrhodam

207 Zein was tagged with fluorescein isothiocyanate (FITC) and made into nanopart

208 ing of the film, after a post-treatment with Fluorescein Isothiocyanate (FITC) labeled 8-OHdG antibod

209 of marker identification by imaging a 20 muM fluorescein isothiocyanate (FITC) labelling solution on

210 h format using signaling probes labeled with fluorescein isothiocyanate (FITC) or digoxigenin (Dig),

211 dissociation constant (Kd) of Man-SNPs with fluorescein isothiocyanate (FITC)-concanavalin A (Con A)

212 d DSS plus ATB (DSS+ATB) was demonstrated by fluorescein isothiocyanate (FITC)-dextran translocation

213 e for matrix metalloproteinase-2/9 activity, fluorescein isothiocyanate (FITC)-gelatin.

214 Fluorescein isothiocyanate (FITC)-labeled control siRNA

215 The flux of fluorescein isothiocyanate (FITC)-labeled dextran across

216 ching technique, diffusion coefficients D of fluorescein isothiocyanate (FITC)-pepsin were measured i

217 microscopy measurement after incubation with fluorescein isothiocyanate (FITC)-tagged anti-human IgG.

218 rseradish peroxidase (HRP, R(2) = 0.964) and fluorescein isothiocyanate (FITC, R(2) = 0.973).

219 "switch" consisting of folate conjugated to fluorescein isothiocyanate (folate-FITC) can redirect an

220 ocyanate-labeled IAV in the presence of anti-fluorescein isothiocyanate antibody also resulted in vir

221 For in vivo analyses, we used fluorescein isothiocyanate contact hypersensitivity and

222 etramethyl rhodamine isothiocyanate (TRITC), fluorescein isothiocyanate isomer I(FITC) and DNA molecu

223 sialofetuin (TRITC-AF) as a ST substrate and fluorescein isothiocyanate labeled 3-aminophenylboronic

224 r PEG-like molecules (CH3-PEG5K-FITC (FITC = fluorescein isothiocyanate) and eight-arm PEG20K-FITC) w

225 Intracarotid fluorescein isothiocyanate-BSA infusion was used to dete

226 es per retina, assessed after perfusion with fluorescein isothiocyanate-conjugated concanavalin A, wa

227 smural sections of jejunum were stained with fluorescein isothiocyanate-conjugated isolectin-B4 for e

228 ng transepithelial resistance and passage to fluorescein isothiocyanate-dextran 4 kDa (FD4).

229 electrical resistance, paracellular flux of fluorescein isothiocyanate-dextran 4 kDa, and mRNA expre

230 ithelial electrical resistance and increased fluorescein isothiocyanate-dextran flux (P < .05).

231 ng transepithelial electrical resistance and fluorescein isothiocyanate-dextran flux.

232 Intestinal permeability was investigated by fluorescein isothiocyanate-dextran uptake assay, quantit

233 by jugular vein infusion of (125)I-fibrin or fluorescein isothiocyanate-fibrin labeled emboli in anes

234 Exposure of AMs to fluorescein isothiocyanate-labeled IAV in the presence o

235 Neutrophils were isolated and incubated with fluorescein isothiocyanate-labeled P. gingivalis, and ph

236 fluorous microarray to analyze binding with fluorescein isothiocyanate-labeled PEMV; however, no spe

237 4) was determined by co-immunoprecipitation, fluorescein isothiocyanate-probing, and surface plasmon

238 on revealed the specific binding capacity of fluorescein isothiocyanate-RamAb to VEGFR-2, and no diff

239 nscription during mitosis, as confirmed with fluorescein isothiocyanate-uridine 5'-triphosphate label

240 ith desired functional groups (e.g., -COCH3, fluorescein isothiocyanate; FITC).

241 amplicons to be generated and tagged with a fluorescein label.

242 Fluorescein labeled folic acid was used for flow cytomet

243 completely, thereby conferring protection to fluorescein-labeled Micrococcus lysodeikticus from lysoz

244 luorescence at deeper layers of the skin for fluorescein-labeled siRNA-CYnLIP than solution.

245 The fluorescein-labeled ssDNA amplicons are then analyzed us

246 ized on the lateral flow test strip, and the fluorescein-labeled terminal bound to the antibody-conju

247 line (P = 0.0002) and month 36 (P < 0.0001), fluorescein leakage area at month 36 (P = 0.0137), and g

248 fferent vessels crossing the limbus, time to fluorescein leakage, area, and geometric properties of t

249 of leakage on FA and 1 eye had questionable fluorescein leakage.

250 conjugation and delivery of the model probe fluorescein-maleimide and the medicinal agent paclitaxel

251 ated by impregnating 2.5 muL (0.285 nmol) of fluorescein mercury acetate (FMA) onto the surface of a

252 owed previously undescribed features such as fluorescein-negative intraretinal cystic changes, choroi

253 ded intraocular pressure, lisamine green and fluorescein ocular surface stains.

254 as assessed using CaSO4 beads that contained fluorescein or antibiotics and were pre-coated with huma

255 ithelial electrical resistance and increased fluorescein permeability.

256 No fluorescence was detectable from fluorescein PMs, indicating quenching.

257 Following incubation of L929 cells with fluorescein PMs, there was a gradual increase in intrace

258 s a ~100x increase in signal sensitivity for fluorescein, reducing the limit of detection (LOD) for m

259 concentration had no influence on short-term fluorescein release and pre-coating of beads with body f

260 ts were confirmed using muFFE separations of fluorescein, rhodamine 110, and rhodamine 123 in a low i

261 scent guests, namely coumarin 1, coumarin 4, fluorescein, [Ru(bpy)3 ]Cl2 , and rhodamine B, can be en

262 Each eye had a baseline fluorescein scan prior to any fluorescein dye.

263 is genetically fused to a high-affinity anti-fluorescein scFv antibody fragment (scFvFITC).

264 Supportive measures included corneal fluorescein scores (superior, central, total region) and

265 essfully identified by internalization of FA-fluorescein, showed significantly higher GFP expression

266 nce resonance energy transfer (FRET) between fluorescein site-specifically attached to inserted cyste

267 ing of olefin cross-metathesis with an allyl fluorescein species was used before array analysis.

268 best-corrected visual acuity (BCVA), corneal fluorescein staining (CFS), tear break-up time, and Schi

269 The main efficacy end points were corneal fluorescein staining (CFS), tear film break-up time (TBU

270 SDI score (rs = -0.26, P = .03), and corneal fluorescein staining (rs = -0.28, P = .008).

271 ng a re-epithelialization time analysis with fluorescein staining at 18 and 24 hours.

272 re obscured in the fluorescein angiograms by fluorescein staining from underlying, preexisting laser

273 te analysis revealed that changes in corneal fluorescein staining had predictive value on symptom cha

274 indicate treatment response were, in order, fluorescein staining of the cornea, reduction in foreign

275 topographically correlated with the area of fluorescein staining or with the internal limiting membr

276 Fluorescein staining patterns according to Oxford Schema

277 thout anesthesia) >/=1 and </=10 mm, corneal fluorescein staining score >/=2.0 (0-4 scale), eye dryne

278 score (VAS, both eyes) and inferior corneal fluorescein staining score in the designated study eye.

279 orrelation was seen between OSDI and corneal fluorescein staining scores (rs = 0.67, P = .01).

280 ptoms, tear break up time (TBUT) and corneal fluorescein staining were also prospectively evaluated.

281 ex (OSDI), tear breakup time (TBUT), corneal fluorescein staining, and lissamine staining, have great

282 mia, fluorescein tear break-up time, corneal fluorescein staining, conjunctival lissamine green stain

283 045) but not with tear breakup time, corneal fluorescein staining, or ocular medications used by pati

284 hy (OCT) and slitlamp photography (SLP) with fluorescein staining.

285 lar Surface Disease Index (OSDI) and corneal fluorescein staining.

286 ependent assays (CD154 detection and carboxy-fluorescein succinimidyl ester dilution assays) and 9 in

287 these proteins, we used a CC labeled with a fluorescein tag to measure binding affinity via fluoresc

288 d by fluorescence polarization analysis of a fluorescein-tagged peptide corresponding to pol beta res

289 Here we report the use of a fluorescein-tagged peroxisomal targeting sequence peptid

290 same time with biotin/digoxigenin or biotin/fluorescein tags, respectively.

291 nol red thread test, conjunctival hyperemia, fluorescein tear break-up time, corneal fluorescein stai

292 in, was generated to show utility beyond the fluorescein test molecule.

293 novel chemical probes, ubiquitin C-terminal fluorescein thioesters UbMES and UbFluor, to qualitative

294 We identified fluorescein-trehalose analogues that are metabolically i

295 A detection limit of 12 pM fluorescein was achieved when sampling 20 droplets, and

296 Fluorescein was encapsulated stably in PMs of mean diame

297 when xylem water potential rapidly declined, fluorescein was translocated, on average, farther into m

298 the working principle for the model compound fluorescein, where the organic solvent DMSO is exchanged

299 was not significantly different than that of fluorescein, which did not interact with the capillary s

300 tamol, ibuprofen, tamoxifen, BAY 11-7082 and fluorescein, with accuracy on the scale of micrograms pe